European Growth Companies With High Insider Ownership To Watch

In This Article:

As European markets navigate the complexities of U.S. trade tariffs and shifting monetary policies, the pan-European STOXX Europe 600 Index recently experienced a decline amid these uncertainties. In this environment, growth companies with high insider ownership can be particularly interesting to watch, as their leadership's vested interest may align with shareholder value creation during turbulent times.

Top 10 Growth Companies With High Insider Ownership In Europe

Name

Insider Ownership

Earnings Growth

Elicera Therapeutics (OM:ELIC)

27.8%

97.2%

Vow (OB:VOW)

13.1%

120.9%

Pharma Mar (BME:PHM)

11.8%

40.8%

CD Projekt (WSE:CDR)

29.7%

39.1%

Bergen Carbon Solutions (OB:BCS)

12%

50.8%

XTPL (WSE:XTP)

27.9%

118%

Elliptic Laboratories (OB:ELABS)

22.6%

88.2%

Nordic Halibut (OB:NOHAL)

29.8%

56.3%

Ortoma (OM:ORT B)

27.7%

68.6%

Circus (XTRA:CA1)

26%

51.4%

Click here to see the full list of 229 stocks from our Fast Growing European Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Oryzon Genomics

Simply Wall St Growth Rating: ★★★★★☆

Overview: Oryzon Genomics S.A. is a clinical stage biopharmaceutical company focused on developing epigenetics-based therapeutics for cancer and CNS disorders, with a market cap of €228.43 million.

Operations: Oryzon Genomics S.A. generates revenue through the discovery and development of therapeutics targeting epigenetic mechanisms for cancer and central nervous system disorders.

Insider Ownership: 10.3%

Earnings Growth Forecast: 54% p.a.

Oryzon Genomics, a European growth company with significant insider ownership, is advancing its clinical pipeline with promising developments in psychiatric and neurodegenerative disorders. Recent announcements highlight the progression of vafidemstat into Phase III trials for Borderline Personality Disorder (BPD) following positive Phase IIb results. Despite reporting a net loss of €3.67 million in 2024, Oryzon's revenue is forecast to grow substantially at 52% annually, outpacing the Spanish market significantly.

BME:ORY Ownership Breakdown as at Mar 2025
BME:ORY Ownership Breakdown as at Mar 2025

Attendo

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Attendo AB (publ) operates by providing health and care services across Scandinavia and Finland, with a market cap of SEK9.56 billion.

Operations: The company's revenue is primarily generated from its Care and Health Care Services segment, amounting to SEK18.98 billion.